狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > Gerlachia nivalis (Cesati ex Saccardo) Gams et Muller, anamorph
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號
  • 創(chuàng)e慧谷42號樓B幢401室
Gerlachia nivalis (Cesati ex Saccardo) Gams et Muller, anamorph
Gerlachia nivalis (Cesati ex Saccardo) Gams et Muller, anamorph
規(guī)格:
貨期:
編號:B190405
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產品名稱 Gerlachia nivalis (Cesati ex Saccardo) Gams et Muller, anamorph
商品貨號 B190405
Deposited As Fusarium nivale (Fries) Cesati, anamorph
Strain Designations Fn-2B
Alternate State Monographella nivalis (Schaffnit) Muller, teleomorph
Application
produces fusarenon-X
produces nivalenol
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Type Strain no
Preceptrol® no
Medium ATCC® Medium 336: Potato dextrose agar (PDA)
Growth Conditions
Temperature: 24.0°C
Name of Depositor K Ishii
Chain of Custody
ATCC <<--K Ishii<<--H. Tsunoda
Isolation
barley, Japan
References

Ueno Y, et al. Toxicological approaches to the metabolites of fusaria. I. Screening of toxic strains. Jpn. J. Exp. Med. 41: 257-272, 1971. PubMed: 5315156

Ueno Y, et al. Fusarenon-x, a toxic principle of Fusarium nivale culture filtrate. Experientia 25: 1062, 1969. PubMed: 5307884

Tatsuno T, et al. Nivalenol, a toxic principle of Fusarium nivale. Chem. Pharm. Bull. 16: 2519-2520, 1968. PubMed: 5719033

Ueno Y, Yamakawa H. Antiprotozoal activity of scirpene mycotoxins of Fusarium nivale Fn2B. Jpn. Jpn. J. Exp. Med. 40: 385-390, 1970. PubMed: 5313470

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |